Diagnosis of autoimmune disease

Details Diagnosis of autoimmune disease Diagnosis of autoimmune disease

2005-02-08

2005-02-08

Nolan, Patrick J. (Department: 1644)

Chemistry: analytical and immunological testing

For preexisting immune complex or auto-immune disease

C436S507000, C435S007210, C435S029000

Reexamination Certificate

active

06852546

ABSTRACT:
The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention avoid the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease.

REFERENCES:
patent: 4608341 (1986-08-01), Ambesi-Impiombato
patent: 4609622 (1986-09-01), Kohn et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5401629 (1995-03-01), Harpold et al.
patent: 5436128 (1995-07-01), Harpold et al.
patent: 5814461 (1998-09-01), Bergmann et al.
Akamizu et al. “Cloning chromosomal assignment, and regulation of the rat thyrotropin receptor: Expression of the gene is regulated by thyrotropin, agents that increase cAMP: levels, and thyroid autoantibodies.” Proc. Natl. Acad. Sci. USA 87:5677-5681 (1990).
Saji et al. “Increases in cytosolic Ca++down regulate thyrotropin receptor gene expression by a mechanism different from the cAMP signal,” Biochem. Biophys. Res. Commun. 176:94-101 (1991).
Saji et al. “Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells,” Endocrinology 130:520-523 (1992 a).
Saji et al., “Hormonal regulation of major histocompatibility complex class I genes in rat thyroid FRTL-5 cells: Thyroid-stimulating hormone induces a cAMP-mediated decrease in class I expression,” Proc. Natl. Acad. Sci. USA 89:1944-1948 (1992 b).
Ikuyama et al., “Characterization of the 5′-flanking region of the rat thyrotropin receptor gene,” Mol. Endocrinol. 6:793-804 (1992 a).
Ikuyama et al. “Role of the cyclic adenosine 3′,5′-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter,” Mol. Endocrinol. 6:1701-1715 (1992 b).
Shimura et al. “The cAMP response element in the rat thyrotropin receptor promoter,” J. Biol. Chem. 268:24125-24137 (1993).
Shimura et al. “Thyroid-specific expression and cyclic adenosine 3′, 5′-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1,” Mol. Endocrinol. 8:1049-1069 (1994).
Saji et al. “Regulation of major histocompatibility complex class I gene expression in thyroid cells,” J. Biol. Chem. 272:20096-20107 (1997).
Kirshner et al. “Major histocompatibility class I gene transcription in thyrocytes: a series of interacting regulatory DNA sequence elements mediate thyrotrophin/cyclic-adenosine 3′,5′-monophosphate repression,” Mol. Endocrinol. 14:82-98 (2000).
Brivanlou and Darnell, Jr., “Signal transduction and the control of gene expression,” Science 295 813-818 2002.
Di Cerbo et al. (1999) “Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease,” Biochimie 81:415-24.
Taskén et al. (2004) “Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A,” Physiol. Rev. 84:137-167.
Saji et al. (1991) “Insulin and Insulin-Like Growth Factor-I Inhibit Thyrotropin-Increased Iodide Transport in Serum-Depleted FRTL-5 Rat Thyroid Cells: Modulation of Adenosine 3′,5′-Monophosphate Signal Action,” Endocrinology 128:1136-1143.
Khan et al. (1995) “Arachidonic Acid and Free Fatty Acids as Second Messengers and the Role of Protein Kinase C,” Cell. Signal, 7:171-184.
Leemhius et al. (2002) “The Protein Kinase A Inhibitor H89 Acts on Cell Morphology by Inhibiting Rho Kinase.,” J. Pharmacol. Exp. Ther. 300:1000-1007.
Davies et al. (2000) “Specificity and mechanism of action of some commonly used protein kinase inhibitors,” Biochem. J. 351:95-105.
Cross et al. (1995) “Wortmannin and Its Structural Analogue Demethoxyviridin Inhibit Stimulated Phospholipase A2Activity in Swiss 3T3 cells Wortmannin Is Not a Specific Inhibitor of Phosphatidylinositol 3-kinase,” J. Biol. Chem. 270:25352-25355.
Vlahos et al. (1994) “A Specific Inhibitor of Phospatidylinositol 3-Kinase, 2-(4-Morpholinyl)-8-phenyl-4H-I-benzopyran-4-one (LY2294002),” J. Biol. Chem. 269:5241-5248.
Garcia et al. (2002) “PI3K is Involved in the IGF-I Inhibition of TSH-Induced Sodium/Iodide Symporter Gene Expression,” Mol. Endocrinol. 16: 342-352.
Marocci et al. (1987) “Norepinephrine and Thyrotropin Stimulation of Iodide. Efflux in FRTL-5 Thyroid Cells Involves Metabolites of Arachidonic Acid and is Associated with the iodination of thyroglobulin,” Endocrinology 120:1127-1133.
Kohn et al. (1997) “Characterization of Monoclonal Thyroid Stimulating and Thyrotropin Binding-Inhibiting Autoantibodies from a Hashimoto's Patient Whose Children had Intrauterine and Neonatal Thyroid Disease,” J. Clin. Endocrinol. Metab., 82:3998-4009.
Sarlis, et al. (1997) “Graves' Disease Following Thyrotoxic Painless Thyroiditis. Analysis of Antibody Activates Against Thyrotropin Receptor in Two Cases,” Thyroid 7:829-836.
Wortsman et al. (1998) “Thyrotropin Receptor Epitopes Recognized by Graves' Autoantibodies Developing under Immunosuppressive Therapy,” J. Clin. Endocrinol. Metab. 83:2302-2308.
Adams et al. “The Assessment of Thyroid Function by Tracer Tests with Radioactive Iodine,” New Zealand Med. J., pp 36-41.
McKenzie (1958) “The Bioassay of Thyrotropin in Serum,”Endocrinol. 372-382.
Kriss et al. (1964) “Isolation and Identification of the Long-Acting Thyroid Stimulator and Its Regulation to Hyperthyroidism and Circumscribed Pretibial Myxedema,” J. Clin. Endo. and Metab. 24:1005-1028.
Inui et al. (1998) “Increase of Thyroid Stimulating Activity in Graves' Immunoglobulin-G by High Polyethylene Glycol Concentrations Using Porcine Thyroid Cell Assay,” Thyroid 8:319-325.
Minich et al. (2004) “A Coated Tube Assay for the Detection of Blocking Thyrotropin Receptor Autoantibodies,” J. Clin. Endocr. Metab. 89:352-356.
Davies et al. (1998) “Thyroid Stimulating Antibodies Predict Hyperthyroidism,” J. Clin. Endocr. Metab. 83:3777-3781.
Dumont et al. (2002) “Cross signalling, cell specificity, and physiology,” AJP 283(1):C2-C28.
Kimura et al. (2001) “Regulation of thyroid cell proliferation by TSH and other factors: A critical evaluation of in vitro models,” Endocrine Review 22(5):631-656.
Bell et al. (2002) “TSH signaling and cell survival in 3T3-L1 preadipocytes,” AJP 283(4):C1056-1064.
Kohn et al. (1995) “The Thyrotropin Receptor,” Vitamins and Hormones 50:287-384.
Damante and Di Lauro (1994) “Thyroid-specific gene expression,” Biochem Biophys Acta 1218:255-266.
Czech (2000) “PIP2 and PIP3: Complex Roles at the Cell Surface,” Cell 100:603-606.
Botero and Brown (1998) “Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: Clinical utility in children and adolescents with Graves disease,” J. Pediatr. 132:612-618.
Federman inScientific American Medicine,Scientific American, New York, NY, Dale and Federman (eds.), 1997, Chptr. 3, Section I, pp. 2-22.
Baldet et al. (1987) “Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?” Acta Endocrinol. (Copenh) 116:7-12.
Rapoport et al. (1984) “Clinical Expression with a Human Thyroid Cell Bioassay for Thyroid-Stimulating Immunoglobulin,” J. Clin. Endocrinol. Metabol. 58:332-338.
Yokoyama et al. (1987) “Heterogeneity of Graves' Immunoglobulin G: comparison of Thyrotropin Receptor Antibodies in Serum and in Culture Supernatants of Lymphocytes Transformed by Epstein-Barr Virus Infection,” J. Clin. Endocrinol. Metabol. 64:215-218.
McKenzie and Zakarija (1989) “Clinical Review

Affiliated with

Also associated with

Rating

Diagnosis of autoimmune disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis of autoimmune disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of autoimmune disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3468295